Otsuka Beijing Research Institute
Clinical trials sponsored by Otsuka Beijing Research Institute, explained in plain language.
A research arm of Otsuka, a Japanese pharmaceutical company.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Tolvaptan levels measured in healthy men
Knowledge-focused CompletedThis completed Phase 1 study looked at how a single 7.5mg dose of tolvaptan is processed by the body in 10 healthy men aged 18-40. Researchers measured drug levels in the blood over time to understand its absorption, distribution, and elimination. The study also checked for safet…
Phase: PHASE1 • Sponsor: Otsuka Beijing Research Institute • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:22 UTC
-
Tolvaptan drug tested in healthy men for safety and body processing
Knowledge-focused CompletedThis completed Phase 1 trial tested the drug tolvaptan (7.5mg) in 12 healthy men to see how the body absorbs, processes, and eliminates it. Participants took the tablet eight times over nine days. The study measured drug levels in the blood and checked for side effects, but it wa…
Phase: PHASE1 • Sponsor: Otsuka Beijing Research Institute • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:14 UTC
-
Tolvaptan drug levels measured in healthy volunteers
Knowledge-focused CompletedThis early-phase trial studied how the drug Tolvaptan is processed in the body. 64 healthy men received either a single dose or multiple doses of Tolvaptan. Researchers measured drug levels in the blood to understand its pharmacokinetics.
Phase: PHASE1 • Sponsor: Otsuka Beijing Research Institute • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:09 UTC